[
  {
    "ts": null,
    "headline": "Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think \"Yes\"",
    "summary": "Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.",
    "url": "https://finnhub.io/api/news?id=2b27210dc639008f55722085386c39e4f03be498f7cf2c53229b159423193d36",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762796703,
      "headline": "Is Boston Scientific (BSX) a Solid Growth Stock? 3 Reasons to Think \"Yes\"",
      "id": 137437838,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Boston Scientific (BSX) could produce exceptional returns because of its solid growth attributes.",
      "url": "https://finnhub.io/api/news?id=2b27210dc639008f55722085386c39e4f03be498f7cf2c53229b159423193d36"
    }
  },
  {
    "ts": null,
    "headline": "What's Behind Boston Scientific's Optimism for Urology Growth?",
    "summary": "BSX sees stronger 2026 prospects for Urology, powered by Axonics integration, innovation and global Stone Management momentum.",
    "url": "https://finnhub.io/api/news?id=25b3f2749475e6f9f58be68fc15d2fd51169d840928cc4a4ebf125f0cfab79d9",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1762779000,
      "headline": "What's Behind Boston Scientific's Optimism for Urology Growth?",
      "id": 137395032,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "BSX sees stronger 2026 prospects for Urology, powered by Axonics integration, innovation and global Stone Management momentum.",
      "url": "https://finnhub.io/api/news?id=25b3f2749475e6f9f58be68fc15d2fd51169d840928cc4a4ebf125f0cfab79d9"
    }
  }
]